'Adult failure to thrive' shows medicine's own failures; first human tests of 'base editor’ begin

Some doctors say the "adult failure to thrive" label obscures the patient's story rather than illuminating it. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        In the label 'adult failure to thrive,' medicine reveals its own failures By Eric Boodman Maria Fabrizio for STAT "Failure to thrive" can mean many different things — a slippery phrase in a realm where things were supposed to be definite, measurable. Read More STAT+: Verve Therapeutics begins human tests of first 'base editor,' aiming at heart disease By Matthew Herper and Megan Molteni Verve The biotech's experimental treatment is aimed at a relatively common form of high cholesterol that affects millions of people. Read More Citing risk from Omicron variant BA.5, White House urges Americans to get Covid-19 boosters By Andrew Joseph Susan Walsh/AP Health officials stressed they have tools to handle the ascendant Covid variant, even while underscoring its spread. Read More Sponsor content by ALNYLAM PHARMACEUTICALS "Silencing" the expression of disease-causing genes using RNA interference (RNAi) During gene expression, errors in DNA can result in faulty mRNA that cause or contribute to disease. Alnylam's RNAi therapeutics utilize specially designed small interfering RNA (siRNA) to target and degrade these mRNA, treating disease at source. Learn how. STAT+: 'Eye-opening': The Covid-19 pandemic accelerated antimicrobial resistance across the U.S. By Ed Silverman James Archer/CDC During the pandemic's first year, more than 29,400 people died from antimicrobial-resistant infections commonly associated with health care. Read More Apgar scores are less predictive of infant mortality for Black babies than white ones, study finds By Akila Muthukumar Adobe Apgar scores given to newborns minutes after birth are a less accurate predictor of infant mortality for Black babies than other children. Read More Opinion: FDA rule would facilitate prescription-to-OTC switches but nix a third class of drugs By Martha Rumore The FDA's proposed Additional Condition for Nonprescription Use drug category would expand the number of over-the-counter medicines. Read More Tuesday, July 12, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser